A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E DVolume:
25
Year:
2010
Language:
english
Pages:
7
DOI:
10.1038/leu.2010.226
File:
PDF, 381 KB
english, 2010